Splicing switch of an epigenetic regulator by RNA helicases promotes tumor-cell invasiveness

Nature Structural and Molecular Biology

Volumn 19, Issue 11, 2012, Pages 1139-1146

  Dardenne, Etienne ^a   Pierredon, Sandra ^a   Driouch, Keltouma ^b   Gratadou, Lise ^a   Lacroix Triki, Magali ^a   Espinoza, Micaela Polay ^a   Zonta, Eleonora ^a   Germann, Sophie ^a   Mortada, Hussein ^a   Villemin, Jean Philippe ^a   Dutertre, Martin ^a   Lidereau, Rosette ^b   Vagner, Stéphan ^a   Auboeuf, Didier ^a  

^a INSERM   (France)

^b INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; DNA; EXTRACELLULAR SUPEROXIDE DISMUTASE; HISTONE; HISTONE H2A; HISTONE MACROH2A1; RNA HELICASE; RNA HELICASE DDX17; RNA HELICASE DDX5; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; CHROMATIN; CONTROLLED STUDY; EPIGENETICS; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION STATE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR CELL;

EID: 84869097406     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb.2390     Document Type: Article

References (59)

1. Füllgrabe, J., Kavanagh, E. & Joseph, B. Histone onco-modifications. Oncogene 30, 3391-3403 (2011).
2. Portela, A. & Esteller, M. Epigenetic modifications and human disease. Nat. Biotechnol. 28, 1057-1068 (2010).
3. Dalvai, M. & Bystricky, K. The role of histone modifications and variants in regulating gene expression in breast cancer. J. Mammary Gland Biol. Neoplasia 15, 19-33 (2010).
4. Kapoor, A. et al. The histone variant macroH2A suppresses melanoma progression through regulation of CDK8. Nature 468, 1105-1109 (2010).
5. Srivastava, N., Gochhait, S., de Boer, P. & Bamezai, R.N. Role of H2AX in DNA damage response and human cancers. Mutat. Res. 681, 180-188 (2009).
6. Valdés-Mora, F. et al. Acetylation of H2A.Z is a key epigenetic modification associated with gene deregulation and epigenetic remodeling in cancer. Genome Res. 22, 307-321 (2012).
7. Sporn, J.C. et al. Histone macroH2A isoforms predict the risk of lung cancer recurrence. Oncogene 28, 3423-3428 (2009).
8. Novikov, L. et al. QKI-mediated alternative splicing of the histone variant macroH2A1 regulates cancer cell proliferation. Mol. Cell. Biol. 31, 4244-4255 (2011).
9. Venables, J.P. et al. Cancer-associated regulation of alternative splicing. Nat. Struct. Mol. Biol. 16, 670-676 (2009).
10. Dutertre, M. et al. Exon-based clustering of murine breast tumor transcriptomes reveals alternative exons whose expression is associated with metastasis. Cancer Res. 70, 896-905 (2010).
11. David, C.J. & Manley, J.L. Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev. 24, 2343-2364 (2010).
12. Dutertre, M., Vagner, S. & Auboeuf, D. Alternative splicing and breast cancer. RNA Biol. 7, 403-411 (2010).
13. Stamm, S. et al. Function of alternative splicing. Gene 344, 1-20 (2005). (Pubitemid 40126788)
14. Pan, Q., Shai, O., Lee, L.J., Frey, B.J. & Blencowe, B.J. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet. 40, 1413-1415 (2008).
15. Witten, J.T. & Ule, J. Understanding splicing regulation through RNA splicing maps. Trends Genet. 27, 89-97 (2011).
16. Aslakson, C.J. & Miller, F.R. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 52, 1399-1405 (1992).
17. Bemmo, A. et al. Exon-level transcriptome profiling in murine breast cancer reveals splicing changes specific to tumors with different metastatic abilities. PLoS ONE 5, e11981 (2010).
18. Fuller-Pace, F.V. & Moore, H.C. RNA helicases p68 and p72: multifunctional proteins with important implications for cancer development. Future Oncol. 7, 239-251 (2011).
19. Janknecht, R. Multi-talented DEAD-box proteins and potential tumor promoters: p68 RNA helicase (DDX5) and its paralog, p72 RNA helicase (DDX17). Am. J. Transl. Res 2, 223-234 (2010).
20. Bates, G.J. et al. The DEAD box protein p68: a novel transcriptional coactivator of the p53 tumour suppressor. EMBO J. 24, 543-553 (2005). (Pubitemid 40343256)
21. Endoh, H. et al. Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor alpha. Mol. Cell. Biol. 19, 5363-5372 (1999). (Pubitemid 29339895)
22. Hönig, A., Auboeuf, D., Parker, M.M., O'Malley, B.W. & Berget, S.M. Regulation of alternative splicing by the ATP-dependent DEAD-box RNA helicase p72. Mol. Cell Biol. 22, 5698-5707 (2002). (Pubitemid 34815820)
23. Guil, S. et al. Roles of hnRNP A1, SR proteins, and p68 helicase in c-H-ras alternative splicing regulation. Mol. Cell Biol. 23, 2927-2941 (2003). (Pubitemid 36403089)
24. Kar, A. et al. RNA Helicase p68 (DDX5) regulates tau exon 10 splicing by modulating a stem-loop structure at the 5′ splice site. Mol. Cell. Biol. 31, 1812-1821 (2011).
25. Thomas, P.D. et al. PANTHER: a library of protein families and subfamilies indexed by function. Genome Res. 13, 2129-2141 (2003). (Pubitemid 37161770)
26. Gamble, M.J., Frizzell, K.M., Yang, C., Krishnakumar, R. & Kraus, W.L. The histone variant macroH2A1 marks repressed autosomal chromatin, but protects a subset of its target genes from silencing. Genes Dev. 24, 21-32 (2010).
27. Buschbeck, M. et al. The histone variant macroH2A is an epigenetic regulator of key developmental genes. Nat. Struct. Mol. Biol. 16, 1074-1079 (2009).
28. Timinszky, G. et al. A macrodomain-containing histone rearranges chromatin upon sensing PARP1 activation. Nat. Struct. Mol. Biol. 16, 923-929 (2009).
29. Gamble, M.J. & Kraus, W.L. Multiple facets of the unique histone variant macroH2A: from genomics to cell biology. Cell Cycle 9, 2568-2574 (2010).
30. Grek, C.L. & Tew, K.D. Redox metabolism and malignancy. Curr. Opin. Pharmacol. 10, 362-368 (2010).
31. Pani, G., Galeotti, T. & Chiarugi, P. Metastasis: cancer cell′s escape from oxidative stress. Cancer Metastasis Rev. 29, 351-378 (2010).
32. Chaiswing, L. & Oberley, T.D. Extracellular/microenvironmental redox state. Antioxid. Redox Signal. 13, 449-465 (2010).
33. Mori, K., Shibanuma, M. & Nose, K. Invasive potential induced under long-term oxidative stress in mammary epithelial cells. Cancer Res. 64, 7464-7472 (2004). (Pubitemid 39372089)
34. Teoh, M.L., Fitzgerald, M.P., Oberley, L.W. & Domann, F.E. Overexpression of extracellular superoxide dismutase attenuates heparanase expression and inhibits breast carcinoma cell growth and invasion. Cancer Res. 69, 6355-6363 (2009).
35. Svensk, A.M., Soini, Y., Paakko, P., Hiravikoski, P. & Kinnula, V.L. Differential expression of superoxide dismutases in lung cancer. Am. J. Clin. Pathol. 122, 395-404 (2004). (Pubitemid 39145545)
36. Abdelhaleem, M. Helicases: an overview. Methods Mol. Biol. 587, 1-12 (2010).
37. Yang, L., Lin, C. & Liu, Z.R. P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing Axin from β-catenin. Cell 127, 139-155 (2006). (Pubitemid 44466634)
38. Germann, S. et al. Dual role of the ddx5/ddx17 RNA helicases in the control of the pro-migratory NFAT5 transcription factor. Oncogene 618, 1038-1048 (2012).
39. Wang, D. et al. RNA helicase DDX5 regulates microRNA expression and contributes to cytoskeletal reorganization in basal breast cancer cells. Mol. Cell Proteomics 11, M111.011932 (2012).
40. Shin, S., Rossow, K.L., Grande, J.P. & Janknecht, R. Involvement of RNA helicases p68 and p72 in colon cancer. Cancer Res. 67, 7572-7578 (2007). (Pubitemid 47281348)
41. Mooney, S.M., Grande, J.P., Salisbury, J.L. & Janknecht, R. Sumoylation of p68 and p72 RNA helicases affects protein stability and transactivation potential. Biochemistry 49, 1-10 (2010).
42. Wortham, N.C. et al. The DEAD-box protein p72 regulates ERα-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ERα-positive breast cancer. Oncogene 28, 4053-4064 (2009).
43. Yang, L., Lin, C. & Liu, Z.R. Phosphorylations of DEAD box p68 RNA helicase are associated with cancer development and cell proliferation. Mol. Cancer Res. 3, 355-363 (2005). (Pubitemid 40905627)
44. Carter, C.L., Lin, C., Liu, C.Y., Yang, L. & Liu, Z.R. Phosphorylated p68 RNA helicase activates Snail1 transcription by promoting HDAC1 dissociation from the Snail1 promoter. Oncogene 29, 5427-5436 (2010).
45. Causevic, M. et al. Overexpression and poly-ubiquitylation of the DEAD-box RNA helicase p68 in colorectal tumours. Oncogene 20, 7734-7743 (2001). (Pubitemid 33121946)
46. Jacobs, A.M. et al. SUMO modification of the DEAD box protein p68 modulates its transcriptional activity and promotes its interaction with HDAC1. Oncogene 26, 5866-5876 (2007).
47. Mooney, S.M., Goel, A., Dassoro, A.B., Salisbury, J.L. & Janknecht, R. Pleiotropic effects of p300-mediated acetylation on p68 and p72 RNA helicase. J. Biol. Chem. 285, 30443-30452 (2010).
48. Sporn, J.C. & Jung, B. Differential regulation and predictive potential of MacroH2A1 isoforms in colon cancer. Am. J. Pathol. 180, 2516-2526 (2012).
49. Kustatscher, G., Hothorn, M., Pugieux, C., Scheffzek, K. & Ladurner, A.G. Splicing regulates NAD metabolite binding to histone macroH2A. Nat. Struct. Mol. Biol. 12, 624-625 (2005). (Pubitemid 40980814)
50. Krishnakumar, R. & Kraus, W.L. The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets. Mol. Cell 39, 8-24 (2010).
51. Giansanti, V., Dona, F., Tillhon, M. & Scovassi, A.I. PARP inhibitors: new tools to protect from inflammation. Biochem. Pharmacol. 80, 1869-1877 (2010).
52. Cyr, A.R. & Domann, F.E. The redox basis of epigenetic modifications: from mechanisms to functional consequences. Antioxid. Redox Signal. 15, 551-589 (2011).
53. Acharya, A., Das, I., Chandhok, D. & Saha, T. Redox regulation in cancer: a double-edged sword with therapeutic potential. Oxid. Med. Cell. Longev. 3, 23-34 (2010).
54. Weaver, A.M. Regulation of cancer invasion by reactive oxygen species and Tks family scaffold proteins. Sci. Signal. 2, pe56 (2009).
55. Svineng, G., Ravuri, C., Rikardsen, O., Huseby, N.E. & Winberg, J.O. The role of reactive oxygen species in integrin and matrix metalloproteinase expression and function. Connect. Tissue Res. 49, 197-202 (2008).
56. Radisky, D.C. et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436, 123-127 (2005). (Pubitemid 40966197)
57. Li, X. et al. The atypical histone macroH2A1.2 interacts with HER-2 in cancer cells. J. Biol. Chem. 287, 23171-23183 (2012).
58. Luco, R.F., Allo, M., Schor, I.E., Kornblihtt, A.R. & Misteli, T. Epigenetics in alternative pre-mRNA splicing. Cell 144, 16-26 (2011).
59. Bittencourt, D. et al. Cotranscriptional splicing potentiates the mRNA production from a subset of estradiol-stimulated genes. Mol. Cell. Biol. 28, 5811-5824 (2008).